Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class ... (to the fingers and toes causing open sor...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> TECHNOLOGY

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

Date:6/20/2008

to the fingers and toes causing open sores. DUs are painful, with a debilitating impact on patients' daily life, often making it impossible to work and undertake even simple day-to-day activities, particularly those associated with fingertip function. Reducing the occurrence of new DUs is an important and achievable treatment goal in SSc.

In the EU Tracleer(R) is indicated to reduce the number of new digital ulcers in patients with systemic sclerosis and ongoing digital ulcer disease. Tracleer(R) has been shown to improve hand function (i.e. dressing and hygiene) in patients with scleroderma-induced digital ulcers.

Requires attention to two significant safety concerns: Potential for serious liver injury (including rare cases of liver failure and unexplained hepatic cirrhosis in a setting of close monitoring) -- Liver monitoring of all patients is essential prior to initiation of treatment and monthly thereafter. High potential for major birth defects -- Pregnancy must be excluded and prevented by two forms of birth control; monthly pregnancy tests should be obtained. Because of these risks, Tracleer(R) is only supplied through a controlled distribution.

References

1. Galie N, Rubin LJ, Hoeper MM et al. Treatment of patients with mildly

symptomatic pulmonary arterial hypertension with bosentan (EARLY

study): a double-blind, randomised controlled trial. The Lancet 2008;

371: 2093-2100.

2. Channick RN, Simonneau G, Sitbon O et al. Effects of the dual

endothelin-receptor antagonist bosentan in patients with pulmonary

hypertension: a randomised placebo-controlled study. The Lancet 2001;

358: 1119-23 (Study 351).

3. Rubin LJ, Badesch DB, Barst RJ et al. Bosentan therapy for pulmonary

arterial hypertension. NEJM 2002; 346: 896-903 (BREATHE-1).

4. Sitbon O, Humbert M, Jais X et al. Long-term response to calcium

channel blockers in idiopathic pulmonary
'/>"/>

SOURCE Actelion Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
2. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
3. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
4. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
5. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
6. Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
7. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
8. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
9. Analysis of Ulcerative Colitis (UC) Time to Symptom Resolution Data from Pivotal Study of LIALDA(TM) (mesalamine) Presented at DDW
10. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
11. Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol

Post Your Comments:

(Date:5/24/2013)... -- BD (Becton, Dickinson and Company) (NYSE: BDX ), ... will present at the Deutsche Bank 38 th Annual ... a.m. (ET). A live webcast of BD,s ... www.bd.com/investors and will be available for replay through ... BD is a leading global medical technology company that ...

(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately. Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...

(Date:5/24/2013)... , May 24, 2013 Heska Corporation (NASDAQ: HSKA, ... and specialty products, announced today that Dr. Robert ... and Jason Napolitano , executive vice president ... Marcum MicroCap Conference, which is being held May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...

Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2 Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2

[0] BD to Present at the Deutsche Bank 38th Annual Health Care Conference [0] Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.[0] Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference

... to a new market research report " ... (ICs, Thermostat, Thermistor, Resistive Temperature Detectors (RTDs), Thermocouple) & ... " published by MarketsandMarkets ( http://www.marketsandmarkets.com ), the ... was $3.27 billion and is expected to reach $4.51 ...

... 29, 2012 Cempra, Inc. (NASDAQ: CEMP ) ... and chief executive officer, will present at the Cowen ... a.m. EST, March 6, 2012, at The Boston Marriott ... overview of the company,s two leading antibiotic clinical programs, ...

Cached Medicine Technology:MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 2 MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 3 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference 2

MarketsandMarkets: Global Temperature Sensors Market Worth $4.51 Billion by 2016 Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference

(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...

(Date:5/25/2013)... May 25, 2013 Providing patients with their ... Doc team of weight management professionals. But, aside from educating ... effectively, Diet Doc’s hCG diets also provide patients, ... during childhood like bullying, more control over their lives by ... dealing with the underlying factors of weight gain derived from ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...

(Date:5/25/2013)... For college students, few events ... they are turning to prescription stimulants like Adderall ... more on this, go to http://www.sciencedaily.com/releases/2013/05/130501145151.htm . ... that students who pick up Adderall, “just to ... developing a physical and psychological dependency. While initially ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... Director of National Institutes of HealthNEW YORK, Feb. 3 ... the election of Dr. Elias A. Zerhouni , the ... leader in biomedical research, to its Board of Directors."We are ... of Directors," said Dr. Maria C. Freire , President ...

... to Chief Marketing Officer and PACS Industry Veteran ... ManagerWASHINGTON, Feb. 3 Compressus, Inc., leaders in ... team with the promotion of Janine Broda to ... Shawn Gibbons as vice president and general manager ...

... Feb. 3 The Female Health Company (NYSE Alternext: ... conference call to discuss its operating results for the ... (EST) on Tuesday, February 10, 2009. The Company ... the same day. Shareholders and other interested parties may ...

... Go Healthy, Inc. (Pink Sheets: GOHE) announced today that ... for development of major sports relationships at meetings held ... developing partnership with a sports entity, whose members are ... are a major extension of our agreement with Athletic ...

... the best way of spotting trouble, experts say , , ... the stool-based colon cancer tests -- recommended annually for ... to spot potential abnormalities, a German study finds. , ... tests for what is called fecal occult blood -- ...

... ALLEGAN, Mich., Feb. 3 Perrigo Company,(Nasdaq: PRGO ; TASE) today announced results for its fiscal year 2009 second,quarter and six months that ended December 27, ... Perrigo Company, ... Second Quarter Six Months, ... 2009 2008 2009 ...

Lasker Foundation Welcomes Elias Zerhouni to Board of Directors Compressus Bolsters Executive Team to Expand Interoperability Market Pioneered by MEDxConnect(TM)The Female Health Company Schedules First Quarter Conference Call for February 10, 2009 Go Healthy Participates in Super Bowl Events and Developing Sports Relationships Stool-Based Colon Cancer Tests Vary Widely in Accuracy Perrigo Reports Record Second Quarter Sales

Unique supportive clavicle splint. Features front closure design for convenience in application. Comfortable padding over clavicle area....

Indicated for treatment of patella instability...

... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...

... pain relief, stabilization and comfort for patient ... ,The Aspen® "Low Profile" LSO provides immediate ... tightened, using the LeverLatch mechanism, the brace ... of functional mobility and, in many cases, ...

Medicine Products:

Front Closure Clavicle Support 13 Patella Stabilizer w/Cor-Trak Buttress Comfor™ Clavicle Brace - Buckle Closure Aspen® LSO